Desvenlafaxine (Pristiq) vs. Placebo in the Treatment of Chronic Depression.
Phase of Trial: Phase IV
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Depressive disorders; Dysthymic disorder
- Focus Therapeutic Use
- 07 Sep 2017 Status changed from recruiting to completed.
- 01 Mar 2012 New trial record